{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:46:02Z","timestamp":1791585962709,"version":"4.3.4"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The complex interplay between parasites and cancer is yielding promising advances in the field of cancer therapeutics. This study explored the in vitro anti-cancer potential of parasite immunomodulators (antigens and antibodies) of\n                    <jats:italic>Schistosoma mansoni<\/jats:italic>\n                    ,\n                    <jats:italic>Trichinella spiralis<\/jats:italic>\n                    , and\n                    <jats:italic>Toxoplasma gondii<\/jats:italic>\n                    on human HT-29 colorectal and HepG2 hepatocellular carcinoma cells using the MTT assay. Results revealed that those parasites\u2019 immunomodulators exhibited antineoplastic activity and demonstrated a statistically significant inhibition of both cancer cell lines\u2019 proliferation (P \u02c20.05). Notably,\n                    <jats:italic>Trichinella spiralis<\/jats:italic>\n                    antigens and antibodies and anti-\n                    <jats:italic>Toxoplasma gondii<\/jats:italic>\n                    antibodies demonstrated the most statistically significant inhibitory effects on HT-29 colorectal cancer cells (36.65%, 49.9% and 50.43% respectively). For HepG2 hepatocellular carcinoma cells,\n                    <jats:italic>Trichinella spiralis<\/jats:italic>\n                    antigens and antibodies, as well as\n                    <jats:italic>Toxoplasma gondii<\/jats:italic>\n                    antigen, displayed the most statistically significant inhibitory effects (38.27%, 48.25% and 34.68% respectively). Interestingly, parasitic antibodies are particularly noteworthy, exhibiting the most significant inhibitory effects on both cancer cell lines. To the best of our knowledge, this is the first study to demonstrate the antineoplastic activity of parasites\u2019 antibodies against human colorectal cancer and hepatocellular carcinoma. These findings could enlighten the path for promising cancer therapeutic candidates. Future research should explore the antineoplastic potential of a broader range of parasites\u2019 immunomodulators and identify their mechanisms of action. This could represent a qualitative shift towards the development of innovative cancer therapeutic antibodies and cancer vaccine candidates of parasitic origin for cancer-targeted immunotherapy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13027-025-00715-6","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:04:06Z","timestamp":1765519446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Parasites\u2019 immunomodulators: a breakthrough in immunotherapeutics displaying antineoplastic activity against human colorectal and hepatocellular carcinoma cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Nahla","family":"El Skhawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"1","key":"715_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"715_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/gutjnl-2024-333227","volume":"74","author":"P Danpanichkul","year":"2025","unstructured":"Danpanichkul P, et al. Epidemiology of Gastrointestinal cancers: a systematic analysis from the global burden of disease study 2021. Gut. 2025;74(1):26\u201334.","journal-title":"Gut"},{"issue":"1","key":"715_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, et al. Global burden of 5 major types of Gastrointestinal cancer. Gastroenterology. 2020;159(1):335\u2013e34915.","journal-title":"Gastroenterology"},{"key":"715_CR4","doi-asserted-by":"crossref","unstructured":"Kinsey E, Lee HM. Management of hepatocellular carcinoma in 2024: the multidisciplinary paradigm in an evolving treatment landscape. Cancers (Basel). 2024;16(3).","DOI":"10.3390\/cancers16030666"},{"key":"715_CR5","doi-asserted-by":"crossref","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020: pp. 1\u201318.","DOI":"10.1038\/s41577-020-0306-5"},{"issue":"2","key":"715_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/1573394718666220915114659","volume":"19","author":"M Fasihi-Karami","year":"2023","unstructured":"Fasihi-Karami M, et al. Association between some helminths and tumorigenesis through immunological and biochemical factors. Curr Cancer Ther Rev. 2023;19(2):96\u2013102.","journal-title":"Curr Cancer Ther Rev"},{"issue":"1","key":"715_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40001-024-02057-2","volume":"29","author":"MM Eissa","year":"2024","unstructured":"Eissa MM, Salem AE, El N, Skhawy. Parasites revive hope for cancer therapy. Eur J Med Res. 2024;29(1):1\u201356.","journal-title":"Eur J Med Res"},{"issue":"1","key":"715_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13027-025-00679-7","volume":"20","author":"MM Eissa","year":"2025","unstructured":"Eissa MM, El-Faham MH, Skhawy NE. Bridging the gap for diverse applications of parasites as advanced cancer therapeutics: current progress and future directions. Infect Agent Cancer. 2025;20(1):53.","journal-title":"Infect Agent Cancer"},{"key":"715_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1385\/CRIAI:26:1:15","volume":"26","author":"M Yazdanbakhsh","year":"2004","unstructured":"Yazdanbakhsh M, Matricardi PM. Parasites and the hygiene hypothesis: regulating the immune system? Clin Rev Allergy Immunol. 2004;26:15\u201323.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"715_CR10","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.11752","volume":"98","author":"H Akgul","year":"2003","unstructured":"Akgul H, et al. Echinococcus against cancer: why not? Cancer. 2003;98(9):1995\u20139.","journal-title":"Cancer"},{"key":"715_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1590\/S0036-46652003000200007","volume":"45","author":"SB Garcia","year":"2003","unstructured":"Garcia SB, et al. A retrospective study of histopathological findings in 894 cases of megacolon: what is the relationship between megacolon and colonic cancer? Rev Inst Med Trop Sao Paulo. 2003;45:91\u20133.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"12","key":"715_CR12","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2217\/fon.12.155","volume":"8","author":"HY Darani","year":"2012","unstructured":"Darani HY, Yousefi M. Parasites and cancers: parasite antigens as possible targets for cancer immunotherapy. Future Oncol. 2012;8(12):1529\u201335.","journal-title":"Future Oncol"},{"issue":"281","key":"715_CR13","first-page":"486","volume":"32","author":"M Badri-Chookami","year":"2014","unstructured":"Badri-Chookami M, et al. Effect of alive Protoscoleces of hydatid cyst on the growth of melanoma cells in mouse model. I U M S. 2014;32(281):486\u201392.","journal-title":"I U M S"},{"issue":"10","key":"715_CR14","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00432-022-04036-8","volume":"148","author":"SA Bahwal","year":"2022","unstructured":"Bahwal SA, et al. Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model. J Cancer Res Clin Oncol. 2022;148(10):2743\u201357.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"13","key":"715_CR15","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-12-1974","volume":"73","author":"JR Baird","year":"2013","unstructured":"Baird JR, et al. Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment. Cancer Res. 2013;73(13):3842\u201351.","journal-title":"Cancer Res"},{"issue":"9","key":"715_CR16","doi-asserted-by":"publisher","first-page":"e24407","DOI":"10.1371\/journal.pone.0024407","volume":"6","author":"L Chen","year":"2011","unstructured":"Chen L, et al. Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity. PLoS ONE. 2011;6(9):e24407.","journal-title":"PLoS ONE"},{"issue":"9","key":"715_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pt.2013.07.001","volume":"29","author":"BA Fox","year":"2013","unstructured":"Fox BA, et al. Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines. Trends Parasitol. 2013;29(9):431\u20137.","journal-title":"Trends Parasitol"},{"key":"715_CR18","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s00436-021-07283-9","volume":"120","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Antitumor effects of a Toxoplasma mutant lacking lactate dehydrogenases. Parasitol Res. 2021;120:3335\u20139.","journal-title":"Parasitol Res"},{"issue":"6","key":"715_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.12057","volume":"23","author":"Y Liang","year":"2021","unstructured":"Liang Y, et al. Plasmodium infection prevents recurrence and metastasis of hepatocellular carcinoma possibly via Inhibition of the epithelial\u2013mesenchymal transition. Mol Med Rep. 2021;23(6):1\u201310.","journal-title":"Mol Med Rep"},{"issue":"8","key":"715_CR20","doi-asserted-by":"publisher","first-page":"e0200433","DOI":"10.1371\/journal.pone.0200433","volume":"13","author":"SL Ranasinghe","year":"2018","unstructured":"Ranasinghe SL, et al. Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer. PLoS ONE. 2018;13(8):e0200433.","journal-title":"PLoS ONE"},{"key":"715_CR21","first-page":"129","volume":"37","author":"J-D Choo","year":"2005","unstructured":"Choo J-D. Inhibitory effects of Toxoplasma antigen on proliferation and invasion of human glioma cells. J Korean Neurosurg Soc. 2005;37:129\u201336.","journal-title":"J Korean Neurosurg Soc"},{"issue":"2","key":"715_CR22","first-page":"461","volume":"28","author":"MM Eissa","year":"1998","unstructured":"Eissa MM, et al. Autoclaved cercarial vaccine: a new hope against schistosomiasis parasitologic, histopathologic and Immunologic studies. J Egypt Soc Parasitol. 1998;28(2):461\u201379.","journal-title":"J Egypt Soc Parasitol"},{"issue":"1","key":"715_CR23","first-page":"219","volume":"33","author":"MM Eissa","year":"2003","unstructured":"Eissa MM, et al. Vaccination trial against experimental trichinellosis using autoclaved Trichinella spiralis larvae vaccine (ATSLV). J Egypt Soc Parasitol. 2003a;33(1):219\u201328.","journal-title":"J Egypt Soc Parasitol"},{"issue":"3","key":"715_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.exppara.2012.05.001","volume":"131","author":"MM Eissa","year":"2012","unstructured":"Eissa MM, et al. Initial characterization of an autoclaved Toxoplasma vaccine in mice. Exp Parasitol. 2012;131(3):310\u20136.","journal-title":"Exp Parasitol"},{"issue":"4","key":"715_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1179\/146532806X152890","volume":"26","author":"EAG Khalil","year":"2006","unstructured":"Khalil EAG, et al. Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved leishmania major\u2009+\u2009BCG) in children: an extended phase II study. Ann Trop Paediatr. 2006;26(4):357\u201361.","journal-title":"Ann Trop Paediatr"},{"key":"715_CR26","doi-asserted-by":"publisher","first-page":"111684","DOI":"10.1016\/j.msec.2020.111684","volume":"120","author":"OA Tosyali","year":"2021","unstructured":"Tosyali OA, et al. Nano-co-delivery of lipophosphoglycan with soluble and autoclaved leishmania antigens into PLGA nanoparticles: evaluation of in vitro and in vivo immunostimulatory effects against visceral leishmaniasis. Mater Sci Eng C. 2021;120:111684.","journal-title":"Mater Sci Eng C"},{"issue":"2","key":"715_CR27","first-page":"541","volume":"33","author":"MM Eissa","year":"2003","unstructured":"Eissa MM, et al. Further studies on autoclaved cercarial vaccine against schistosomiasis: safety, longevity and stability. J Egypt Soc Parasitol. 2003;33(2):541\u201360.","journal-title":"J Egypt Soc Parasitol"},{"issue":"21","key":"715_CR28","first-page":"1","volume":"18","author":"MM Eissa","year":"2023","unstructured":"Eissa MM, et al. Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against Ehrlich solid carcinoma with evidence of shared antigens by comparative Immunoblotting. Infect Agents Cancer. 2023;18(21):1\u201313.","journal-title":"Infect Agents Cancer"},{"key":"715_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-023-01994-y","volume":"40","author":"CA Ismail","year":"2023","unstructured":"Ismail CA, et al. Toxoplasma gondii\u2013derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide. Med Oncol. 2023;40:1\u201313.","journal-title":"Med Oncol"},{"issue":"11","key":"715_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0165916","volume":"11","author":"MM Eissa","year":"2016","unstructured":"Eissa MM, et al. Anti-arthritic activity of schistosoma mansoni and Trichinella spiralis derived-antigens in adjuvant arthritis in rats: role of Foxp3\u2009+\u2009Treg cells. PLoS ONE. 2016;11(11):1\u201320.","journal-title":"PLoS ONE"},{"issue":"11","key":"715_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00436-024-08415-7","volume":"123","author":"N El Skhawy","year":"2024","unstructured":"El Skhawy N, et al. Immunomodulatory role of Trichinella spiralis-derived antigen on imiquimod-induced psoriasis in mice model. Parasitol Res. 2024;123(11):397.","journal-title":"Parasitol Res"},{"issue":"1","key":"715_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s40001-025-02531-5","volume":"30","author":"MM Eissa","year":"2025","unstructured":"Eissa MM, et al. Unveiling the anti-neoplastic potential of schistosoma mansoni-derived antigen against breast cancer: a pre-clinical study. Eur J Med Res. 2025;30(1):304.","journal-title":"Eur J Med Res"},{"issue":"1","key":"715_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10637-018-0609-6","volume":"37","author":"MM Eissa","year":"2019","unstructured":"Eissa MM, et al. Immuno-therapeutic potential of schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer. Invest New Drugs. 2019;37(1):47\u201356.","journal-title":"Invest New Drugs"},{"issue":"3","key":"715_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antib9030034","volume":"9","author":"D Zahavi","year":"2020","unstructured":"Zahavi D, Weiner L. Monoclonal antibodies in cancer therapy. Antibodies. 2020;9(3):1\u201320.","journal-title":"Antibodies"},{"issue":"13","key":"715_CR35","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/bph.12955","volume":"172","author":"JC McGrath","year":"2015","unstructured":"McGrath JC, Lilley E. Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol. 2015;172(13):3189\u201393.","journal-title":"Br J Pharmacol"},{"key":"715_CR36","unstructured":"World Medical Association. Declaration of Helsinki: Medical research involving human participants. 2024."},{"key":"715_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0065-308X(08)60475-3","volume":"6","author":"J Pellegrino","year":"1968","unstructured":"Pellegrino J, Katz N. Experimental chemotherapy of schistosomiasis mansoni. Adv Parasitol. 1968;6:233\u201390.","journal-title":"Adv Parasitol"},{"issue":"4","key":"715_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","volume":"34","author":"L Pica-Mattoccia","year":"2004","unstructured":"Pica-Mattoccia L, Cioli D. Sex-and stage-related sensitivity of schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol. 2004;34(4):527\u201333.","journal-title":"Int J Parasitol"},{"key":"715_CR39","doi-asserted-by":"crossref","unstructured":"Wassom DL, Dougherty DA, Dick TA. Trichinella spiralis infections of inbred mice: immunologically specific responses induced by different Trichinella isolates. J Parasitol. 1988: 283\u20137.","DOI":"10.2307\/3282457"},{"issue":"5","key":"715_CR40","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.4049\/jimmunol.140.5.1632","volume":"140","author":"R McLeod","year":"1988","unstructured":"McLeod R, et al. Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital Toxoplasma challenge. J Immunol. 1988;140(5):1632\u20137.","journal-title":"J Immunol"},{"issue":"1","key":"715_CR41","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1038\/s41598-025-88680-3","volume":"15","author":"EF Fadel","year":"2025","unstructured":"Fadel EF, et al. Serological and molecular detection of Toxoplasma gondii among cancer patients in Sohag, upper egypt: a case-control study. Sci Rep. 2025;15(1):5236.","journal-title":"Sci Rep"},{"issue":"7","key":"715_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00262-025-04069-1","volume":"74","author":"MM Eissa","year":"2025","unstructured":"Eissa MM, et al. Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic antibodies. Cancer Immunol Immunother. 2025;74(7):212.","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"715_CR43","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1271\/bbb.70149","volume":"71","author":"B Rajkapoor","year":"2007","unstructured":"Rajkapoor B, et al. Antitumor and cytotoxic effects of phyllanthus polyphyllus on Ehrlich Ascites carcinoma and human cancer cell lines. Biosci Biotechnol Biochem. 2007;71(9):2177\u201383.","journal-title":"Biosci Biotechnol Biochem"},{"key":"715_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6146972","volume":"2019","author":"D Figueroa","year":"2019","unstructured":"Figueroa D, Asaduzzaman M, Young F. Effect of chemotherapeutics and tocopherols on MCF-7 breast adenocarcinoma and KGN ovarian carcinoma cell lines in vitro. Biomed Res Int. 2019;2019:1\u201313.","journal-title":"Biomed Res Int"},{"key":"715_CR45","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1007\/s11033-013-2565-8","volume":"40","author":"S Karadayi","year":"2013","unstructured":"Karadayi S, et al. Does hydatid disease have protective effects against lung cancer? Mol Biol Rep. 2013;40:4701\u20134.","journal-title":"Mol Biol Rep"},{"key":"715_CR46","doi-asserted-by":"publisher","first-page":"106172","DOI":"10.1016\/j.actatropica.2021.106172","volume":"225","author":"J Ding","year":"2022","unstructured":"Ding J, et al. Excretory-secretory product of Trichinella spiralis inhibits tumor cell growth by regulating the immune response and inducing apoptosis. Acta Trop. 2022;225:106172.","journal-title":"Acta Trop"},{"issue":"878724","key":"715_CR47","first-page":"1","volume":"13","author":"S Bahadory","year":"2022","unstructured":"Bahadory S, et al. In vitro anti-gastrointestinal cancer activity of Toxocara canis-derived peptide: analyzing the expression level of factors related to cell proliferation and tumor growth. Front Pharmacol. 2022;13(878724):1\u201310.","journal-title":"Front Pharmacol"},{"key":"715_CR48","first-page":"45","volume":"2","author":"MM Eissa","year":"2022","unstructured":"Eissa MM, et al. Evaluation of cytotoxic activity of live Toxoplasma gondii tachyzoites and Toxoplasma antigen on MCF-7 human breast cancer cell line. EUREKA: Life Sci. 2022;2:45\u201350.","journal-title":"EUREKA: Life Sci"},{"issue":"3\u20134","key":"715_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0304-4017(03)00062-1","volume":"113","author":"BC Saravanan","year":"2003","unstructured":"Saravanan BC, et al. A rapid MTT colorimetric assay to assess the proliferative index of two Indian strains of theileria annulata. Vet Parasitol. 2003;113(3\u20134):211\u20136.","journal-title":"Vet Parasitol"},{"issue":"6","key":"715_CR50","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/15321819.2016.1179644","volume":"37","author":"M Abdel-Latif","year":"2016","unstructured":"Abdel-Latif M, Sakran T. Detection for cross-reactive proteins in filarial worm setaria equina, MCF-7 human breast cancer, and Huh-7 hepatoma cells. J Immunoass Immunochem. 2016;37(6):572\u201384.","journal-title":"J Immunoass Immunochem"},{"issue":"2","key":"715_CR51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.intimp.2014.12.004","volume":"24","author":"M Abdel-Latif","year":"2015","unstructured":"Abdel-Latif M, et al. Immunomodulatory effect of diethylcarbamazine citrate plus filarial excretory\u2013secretory product on rat hepatocarcinogenesis. Int Immunopharmacol. 2015;24(2):173\u201381.","journal-title":"Int Immunopharmacol"},{"key":"715_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fcimb.2022.786543","volume":"12","author":"P Jiang","year":"2022","unstructured":"Jiang P, et al. Identification of a schistosoma Japonicum MicroRNA that suppresses hepatoma cell growth and migration by targeting host FZD4 gene. Front Cell Infect Microbiol. 2022;12:31.","journal-title":"Front Cell Infect Microbiol"},{"key":"715_CR53","doi-asserted-by":"publisher","first-page":"107955","DOI":"10.1016\/j.intimp.2021.107955","volume":"99","author":"M Shakibapour","year":"2021","unstructured":"Shakibapour M, et al. Anti-cancer immunoprotective effects of immunization with hydatid cyst wall antigens in a non-immunogenic and metastatic triple-negative murine mammary carcinoma model. Int Immunopharmacol. 2021;99:107955.","journal-title":"Int Immunopharmacol"},{"key":"715_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-021-05008-6","volume":"14","author":"T-T Yue","year":"2021","unstructured":"Yue T-T, et al. Anti-osteosarcoma effect of antiserum against cross antigen TPD52 between osteosarcoma and Trichinella spiralis. Parasites Vectors. 2021;14:1\u201313.","journal-title":"Parasites Vectors"},{"issue":"2","key":"715_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/0973-1482.144638","volume":"11","author":"MS Seyedeh","year":"2015","unstructured":"Seyedeh MS, et al. Low titer of antibody against Toxoplasma gondii May be related to resistant to cancer. J Cancer Res Ther. 2015;11(2):305\u20137.","journal-title":"J Cancer Res Ther"},{"key":"715_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7819-8-68","volume":"8","author":"OE Salim","year":"2010","unstructured":"Salim OE, et al. Colorectal carcinoma associated with schistosomiasis: a possible causal relationship. World J Surg Oncol. 2010;8:1\u20136.","journal-title":"World J Surg Oncol"},{"key":"715_CR57","doi-asserted-by":"publisher","first-page":"652395","DOI":"10.3389\/fonc.2021.652395","volume":"11","author":"C Hu","year":"2021","unstructured":"Hu C, et al. A schistosoma Japonicum MicroRNA exerts antitumor effects through Inhibition of both cell migration and angiogenesis by targeting PGAM1. Front Oncol. 2021;11:652395.","journal-title":"Front Oncol"},{"key":"715_CR58","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00436-012-3260-8","volume":"112","author":"F Yang","year":"2013","unstructured":"Yang F, et al. A recombined protein (rSj16) derived from schistosoma Japonicum induces cell cycle arrest and apoptosis of murine myeloid leukemia cells. Parasitol Res. 2013;112:1261\u201372.","journal-title":"Parasitol Res"},{"key":"715_CR59","doi-asserted-by":"crossref","unstructured":"Pekkle Lam HY et al. Schistosoma mansoni soluble egg antigen suppresses colorectal cancer growth in vitro and in vivo. J Microbiol Immunol Infect, 2024.","DOI":"10.1016\/j.jmii.2024.11.009"},{"key":"715_CR60","doi-asserted-by":"crossref","unstructured":"Loures MA, Andrade A, Peralta JM. Local response in mouse tumor treated with schistosoma mansoni antigen. Mem Inst Oswaldo Cruz, 1991: pp. 127\u20138.","DOI":"10.1590\/S0074-02761991000700027"},{"key":"715_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1590\/S0037-86821986000100009","volume":"19","author":"FEL Pereira","year":"1986","unstructured":"Pereira FEL, Raso P, Coelho PMZ. Evolution of sarcoma 180 (ascitic tumor) in mice infected with schistosoma mansoni. Rev Soc Bras Med Trop. 1986;19:39\u201342.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"4","key":"715_CR62","first-page":"426","volume":"29","author":"D C\u00e1novas","year":"2012","unstructured":"C\u00e1novas D, Bird N. Human AB serum as an alternative to fetal bovine serum for endothelial and cancer cell culture. ALTEX-ALTERN. 2012;29(4):426\u20138.","journal-title":"ALTEX-ALTERN"},{"issue":"1","key":"715_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yexcr.2018.02.017","volume":"365","author":"JI Heger","year":"2018","unstructured":"Heger JI, et al. Human serum alters cell culture behavior and improves spheroid formation in comparison to fetal bovine serum. Exp Cell Res. 2018;365(1):57\u201365.","journal-title":"Exp Cell Res"},{"key":"715_CR64","first-page":"285","volume":"4","author":"X Li","year":"2008","unstructured":"Li X, et al. Effect of Trichinella on growth of human colorectal carcinoma HCT-8 cells in BALB\/c mice. Chin J Biol. 2008;4:285\u20137.","journal-title":"Chin J Biol"},{"issue":"2","key":"715_CR65","first-page":"223","volume":"48","author":"V Apanasevich","year":"2002","unstructured":"Apanasevich V, Britov V. Antitumor cross-resistance of trichinosis. Vopr Onkol. 2002;48(2):223\u20136.","journal-title":"Vopr Onkol"},{"key":"715_CR66","doi-asserted-by":"crossref","unstructured":"Weatherly NF. Increased survival of Swiss mice given sublethal infections of Trichinella spiralis. J Parasitol, 1970: pp. 748\u201352.","DOI":"10.2307\/3277722"},{"key":"715_CR67","unstructured":"Gong P et al. Observation of anti-tumer effect of Trichinella spirialis in mice on A549 lung cancer cell. Pathogn Biol, 2008: pp. 200\u20132."},{"key":"715_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2023.109708","volume":"115","author":"T Yue","year":"2023","unstructured":"Yue T, et al. Antitumor effect of invasive Lactobacillus plantarum delivering associated antigen gene sHSP between Trichinella spiralis and Lewis lung cancer cells. Int Immunopharmacol. 2023;115:1\u201312.","journal-title":"Int Immunopharmacol"},{"key":"715_CR69","doi-asserted-by":"publisher","first-page":"113366","DOI":"10.1016\/j.biopha.2022.113366","volume":"153","author":"S-H Seo","year":"2022","unstructured":"Seo S-H, et al. PTEN\/AKT signaling pathway related to hTERT downregulation and telomere shortening induced in Toxoplasma GRA16-expressing colorectal cancer cells. Biomed Pharmacother. 2022;153:113366.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"715_CR70","doi-asserted-by":"publisher","first-page":"62","DOI":"10.18632\/oncotarget.27417","volume":"11","author":"J-S Kim","year":"2020","unstructured":"Kim J-S, et al. Toxoplasma gondii GRA8-derived peptide immunotherapy improves tumor targeting of colorectal cancer. Oncotarget. 2020;11(1):62.","journal-title":"Oncotarget"},{"issue":"11","key":"715_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2021-002970","volume":"9","author":"Y-C Zhu","year":"2021","unstructured":"Zhu Y-C, et al. Synergy between Toxoplasma gondii type I \u2206GRA17 immunotherapy and PD-L1 checkpoint Inhibition triggers the regression of targeted and distal tumors. J Immunother Cancer. 2021;9(11):1\u201319.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"715_CR72","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3347\/kjp.2014.52.6.605","volume":"52","author":"K-H Pyo","year":"2014","unstructured":"Pyo K-H, et al. Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment. Korean J Parasitol. 2014;52(6):605.","journal-title":"Korean J Parasitol"},{"issue":"45","key":"715_CR73","doi-asserted-by":"publisher","first-page":"74107","DOI":"10.18632\/oncotarget.12316","volume":"7","author":"K-H Pyo","year":"2016","unstructured":"Pyo K-H, et al. Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in mice. Oncotarget. 2016;7(45):74107.","journal-title":"Oncotarget"},{"issue":"2","key":"715_CR74","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/cells13020111","volume":"13","author":"R Mani","year":"2024","unstructured":"Mani R, et al. A novel protozoa parasite-derived protein adjuvant is effective in immunization with cancer cells to activate the cancer-specific protective immunity and inhibit the cancer growth in a murine model of colorectal cancer. Cells. 2024;13(2):111.","journal-title":"Cells"},{"key":"715_CR75","doi-asserted-by":"publisher","first-page":"899737","DOI":"10.3389\/fonc.2022.899737","volume":"12","author":"J Lu","year":"2022","unstructured":"Lu J, et al. Exosomes derived from dendritic cells infected with Toxoplasma gondii show antitumoral activity in a mouse model of colorectal cancer. Front Oncol. 2022;12:899737.","journal-title":"Front Oncol"},{"key":"715_CR76","first-page":"1","volume":"12","author":"S Zhu","year":"2022","unstructured":"Zhu S, et al. Anti-tumoral effect and action mechanism of exosomes derived from Toxoplasma gondii-infected dendritic cells in mice colorectal cancer. Front Oncol. 2022;12:1\u201313.","journal-title":"Front Oncol"},{"issue":"5","key":"715_CR77","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11626-016-0126-x","volume":"53","author":"M Arul","year":"2017","unstructured":"Arul M, Roslani AC, Cheah SH. Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro. Vitro Cell Dev Biol Anim. 2017;53(5):435\u201347.","journal-title":"Vitro Cell Dev Biol Anim"},{"issue":"1","key":"715_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s43042-023-00394-1","volume":"24","author":"S Motavallihaghi","year":"2023","unstructured":"Motavallihaghi S, et al. In vitro anticancer activity of hydatid cyst fluid on colon cancer cell line (C26). Egypt J Med Hum Genet. 2023;24(1):15.","journal-title":"Egypt J Med Hum Genet"},{"issue":"2013","key":"715_CR79","first-page":"1","volume":"2013","author":"E Berriel","year":"2013","unstructured":"Berriel E, et al. Antitumor activity of human hydatid cyst fluid in a murine model of colon cancer. Sci World J. 2013;2013(2013):1\u20137.","journal-title":"Sci World J"},{"key":"715_CR80","doi-asserted-by":"publisher","first-page":"108501","DOI":"10.1016\/j.exppara.2023.108501","volume":"249","author":"S Rostamirad","year":"2023","unstructured":"Rostamirad S, et al. Inhibition of mouse colon cancer growth following immunotherapy with a fraction of hydatid cyst fluid. Exp Parasitol. 2023;249:108501.","journal-title":"Exp Parasitol"},{"issue":"21","key":"715_CR81","doi-asserted-by":"publisher","first-page":"7845","DOI":"10.3390\/ijms21217845","volume":"21","author":"B-A Jacobs","year":"2020","unstructured":"Jacobs B-A, Prince S, Smith KA. Gastrointestinal nematode-derived antigens alter colorectal cancer cell proliferation and migration through regulation of cell cycle and epithelial-mesenchymal transition proteins. Int J Mol Sci. 2020;21(21):7845.","journal-title":"Int J Mol Sci"},{"key":"715_CR82","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s12253-012-9519-7","volume":"18","author":"Y Ding","year":"2012","unstructured":"Ding Y, et al. The plasmodium circumsporozoite protein, a novel NF-\u03baB inhibitor, suppresses the growth of SW480. Pathol Oncol Res. 2012;18:895\u2013902.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"715_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-022-05291-x","volume":"15","author":"X Yao","year":"2022","unstructured":"Yao X, et al. Plasmodium infection suppresses colon cancer growth by inhibiting proliferation and promoting apoptosis associated with disrupting mitochondrial biogenesis and mitophagy in mice. Parasit Vectors. 2022;15(1):1\u201312.","journal-title":"Parasit Vectors"},{"issue":"5","key":"715_CR84","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/carcin\/22.5.737","volume":"22","author":"E Oliveira","year":"2001","unstructured":"Oliveira E, et al. Chronic trypanosoma Cruzi infection associated with low incidence of 1, 2-dimethylhydrazine-induced colon cancer in rats. Carcinogenesis. 2001;22(5):737\u201340.","journal-title":"Carcinogenesis"},{"issue":"7","key":"715_CR85","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ijc.29910","volume":"138","author":"L Ubillos","year":"2016","unstructured":"Ubillos L, et al. Trypanosoma Cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers. Int J Cancer. 2016;138(7):1719\u201331.","journal-title":"Int J Cancer"},{"issue":"6","key":"715_CR86","doi-asserted-by":"publisher","first-page":"e12825","DOI":"10.1111\/pim.12825","volume":"43","author":"H Huang","year":"2021","unstructured":"Huang H, et al. Antitumour metastasis and the antiangiogenic and antitumour effects of a Eimeria stiedae soluble protein. Parasite Immunol. 2021;43(6):e12825.","journal-title":"Parasite Immunol"},{"issue":"9","key":"715_CR87","doi-asserted-by":"publisher","first-page":"948","DOI":"10.7150\/ijbs.9033","volume":"10","author":"S Le\u00f3n-Cabrera","year":"2014","unstructured":"Le\u00f3n-Cabrera S, et al. Extraintestinal helminth infection reduces the development of colitis-associated tumorigenesis. Int J Biol Sci. 2014;10(9):948.","journal-title":"Int J Biol Sci"},{"key":"715_CR88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fonc.2019.00175","volume":"9","author":"C Hu","year":"2019","unstructured":"Hu C, et al. Schistosoma Japonicum MiRNA-7-5p inhibits the growth and migration of hepatoma cells via cross-species regulation of S-phase kinase-associated protein 2. Front Oncol. 2019;9:175.","journal-title":"Front Oncol"},{"issue":"1","key":"715_CR89","first-page":"867368","volume":"2010","author":"S Hu","year":"2010","unstructured":"Hu S, et al. Anti-inflammatory protein of schistosoma Japonicum directs the differentiation of the wehi\u20103b Jcs cells and mouse bone marrow cells to macrophages. BioMed Res Int. 2010;2010(1):867368.","journal-title":"BioMed Res Int"},{"key":"715_CR90","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.omtn.2019.09.006","volume":"18","author":"Y Lin","year":"2019","unstructured":"Lin Y, et al. Cross-species suppression of hepatoma cell growth and migration by a schistosoma Japonicum MicroRNA. Mol Ther Nucleic Acids. 2019;18:400\u201312.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"715_CR91","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/01.idc.0000269904.90155.ce","volume":"15","author":"E Palumbo","year":"2007","unstructured":"Palumbo E. Association between schistosomiasis and cancer, a review. Infect Dis Clin Pract. 2007;15(3):145\u20138.","journal-title":"Infect Dis Clin Pract"},{"issue":"3","key":"715_CR92","first-page":"929","volume":"28","author":"A Wahib","year":"1998","unstructured":"Wahib A, et al. Cell mediated immune response in chronic liver diseases: schistosomal, viral and neoplastic. J Egypt Soc Parasitol. 1998;28(3):929\u201339.","journal-title":"J Egypt Soc Parasitol"},{"issue":"3","key":"715_CR93","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.actatropica.2013.07.024","volume":"128","author":"MM El-Tonsy","year":"2013","unstructured":"El-Tonsy MM, et al. Schistosoma mansoni infection: is it a risk factor for development of hepatocellular carcinoma? Acta Trop. 2013;128(3):542\u20137.","journal-title":"Acta Trop"},{"issue":"2","key":"715_CR94","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/hep.30192","volume":"72","author":"M Roderfeld","year":"2020","unstructured":"Roderfeld M, et al. Schistosoma mansoni egg-secreted antigens activate hepatocellular carcinoma-associated transcription factors c-Jun and STAT3 in hamster and human hepatocytes. Hepatology. 2020;72(2):626\u201341.","journal-title":"Hepatology"},{"issue":"3\u20134","key":"715_CR95","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.vetpar.2008.10.052","volume":"159","author":"X Wang","year":"2009","unstructured":"Wang X, et al. Trichinella spiralis\u2014A potential anti-tumor agent. Vet Parasitol. 2009;159(3\u20134):249\u201352.","journal-title":"Vet Parasitol"},{"key":"715_CR96","doi-asserted-by":"publisher","first-page":"882608","DOI":"10.3389\/fcimb.2022.882608","volume":"12","author":"P Ruenchit","year":"2022","unstructured":"Ruenchit P, et al. Peptide of Trichinella spiralis infective larval extract that harnesses growth of human hepatoma cells. Front Cell Infect Microbiol. 2022;12:882608.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"715_CR97","first-page":"24","volume":"4","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, et al. Anti-tumoral effect of Trichinella spirialis on Hepa 1\u20136 hepatoma carcinoma cell in the C57BL\/6 mice. J Pathogen Biology. 2009;4(1):24\u20136.","journal-title":"J Pathogen Biology"},{"issue":"3","key":"715_CR98","doi-asserted-by":"publisher","first-page":"935","DOI":"10.31557\/APJCP.2021.22.3.935","volume":"22","author":"FA Elhasawy","year":"2021","unstructured":"Elhasawy FA, et al. The apoptotic effect of Trichinella spiralis infection against experimentally induced hepatocellular carcinoma. Asian Pac J Cancer Prev. 2021;22(3):935.","journal-title":"Asian Pac J Cancer Prev"},{"key":"715_CR99","doi-asserted-by":"crossref","unstructured":"Sadr S, et al. Trichinella spiralis as a potential antitumor agent: an update. World\u2019s Vet J, 2023(1): pp. 65\u201374.","DOI":"10.54203\/scil.2023.wvj7"},{"issue":"6","key":"715_CR100","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1017\/S0031182016002535","volume":"144","author":"J Luo","year":"2017","unstructured":"Luo J, et al. Study on the mitochondrial apoptosis pathways of small cell lung cancer H446 cells induced by Trichinella spiralis muscle larvae esps. Parasitology. 2017;144(6):793\u2013800.","journal-title":"Parasitology"},{"key":"715_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2023.1208538","volume":"10","author":"H Wang","year":"2023","unstructured":"Wang H, et al. Transcriptome profiling of A549 non-small cell lung cancer cells in response to Trichinella spiralis muscle larvae excretory\/secretory products. Front Vet Sci. 2023;10:1\u201311.","journal-title":"Front Vet Sci"},{"key":"715_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exppara.2020.107983","volume":"218","author":"H Wu","year":"2020","unstructured":"Wu H, et al. Trichinella spiralis muscle larvae excretory\/secretory products trigger apoptosis and S-phase arrest of the non-small-cell lung cancer line A549. Exp Parasitol. 2020;218:1\u20136.","journal-title":"Exp Parasitol"},{"issue":"2","key":"715_CR103","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/00034983.1977.11687187","volume":"71","author":"E Meerovitch","year":"1977","unstructured":"Meerovitch E, Bomford R. Macrophage potentiation by Trichinella spiralis. Ann Trop Med Parasit. 1977;71(2):245\u20137.","journal-title":"Ann Trop Med Parasit"},{"key":"715_CR104","doi-asserted-by":"publisher","first-page":"109114","DOI":"10.1016\/j.vetpar.2020.109114","volume":"297","author":"S Piaggi","year":"2021","unstructured":"Piaggi S, et al. Glutathione-S-transferase Omega 1 and nurse cell formation during experimental Trichinella infection. Vet Parasitol. 2021;297:109114.","journal-title":"Vet Parasitol"},{"issue":"3","key":"715_CR105","first-page":"1","volume":"36","author":"E Wing","year":"1979","unstructured":"Wing E, Krahenbuhl J, Remington J. Studies of macrophage function during Trichinella spiralis infection in mice. Immunology. 1979;36(3):1\u201311.","journal-title":"Immunology"},{"issue":"1","key":"715_CR106","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5114\/ceji.2015.50832","volume":"40","author":"S Vasilev","year":"2015","unstructured":"Vasilev S, et al. Experimental immunology necrosis and apoptosis in Trichinella spiralis-mediated tumour reduction. Cent Eur J Immunol. 2015;40(1):42\u201353.","journal-title":"Cent Eur J Immunol"},{"issue":"11","key":"715_CR107","first-page":"1443","volume":"69","author":"N Tsocheva-Gaytandzhieva","year":"2016","unstructured":"Tsocheva-Gaytandzhieva N, et al. Antiproliferative activity against tumour cells of biologically active substances isolated from livers of healthy and Trichinella spiralis infected rats. C R Acad Bulg Sci. 2016;69(11):1443\u20138.","journal-title":"C R Acad Bulg Sci"},{"issue":"2\u20134","key":"715_CR108","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.vetpar.2013.01.050","volume":"194","author":"B Deng","year":"2013","unstructured":"Deng B, et al. Identification of the differentially expressed genes in SP2\/0 myeloma cells from Balb\/c mice infected with Trichinella spiralis. Vet Parasitol. 2013;194(2\u20134):179\u201382.","journal-title":"Vet Parasitol"},{"issue":"3","key":"715_CR109","first-page":"329","volume":"26","author":"A Lubiniecki","year":"1975","unstructured":"Lubiniecki A, Cypess R. Quantitative study of the effect of previous Trichinella spiralis infection on sarcoma 180 ascitic tumor formation in mice. Tropenmed Parasitol. 1975;26(3):329\u201334.","journal-title":"Tropenmed Parasitol"},{"issue":"4","key":"715_CR110","first-page":"429","volume":"30","author":"J Molinari","year":"1979","unstructured":"Molinari J, Carrick L Jr, Lubiniecki A. Influence of Trichinella spiralis infection on development of sarcoma-180 Ascites tumors. Tropenmed Parasitol. 1979;30(4):429\u201333.","journal-title":"Tropenmed Parasitol"},{"issue":"1\u20136","key":"715_CR111","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000231956","volume":"55","author":"J Molinari","year":"1977","unstructured":"Molinari J, Ebersole J. Antineoplastic effects of long-term Trichinella spiralis infection on B-16 melanoma. Int Arch Allergy Appl Immunol. 1977;55(1\u20136):444\u20138.","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"3","key":"715_CR112","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1017\/S0031182000052768","volume":"84","author":"D Pocock","year":"1982","unstructured":"Pocock D, Meerovitch E. The anti-neoplastic effect of trichinellosis in a syngeneic murine model. Parasitology. 1982;84(3):463\u201373.","journal-title":"Parasitology"},{"issue":"1\u20132","key":"715_CR113","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.vetpar.2013.02.021","volume":"196","author":"Y-J Kang","year":"2013","unstructured":"Kang Y-J, et al. Trichinella spiralis infection reduces tumor growth and metastasis of B16-F10 melanoma cells. Vet Parasitol. 2013;196(1\u20132):106\u201313.","journal-title":"Vet Parasitol"},{"key":"715_CR114","first-page":"722","volume":"6","author":"J Liu","year":"2008","unstructured":"Liu J, et al. Observation of Trichinella on C6 glioma in BALB\/c mice. J Apoplexy Nerv Dis. 2008;6:722\u20134.","journal-title":"J Apoplexy Nerv Dis"},{"issue":"1","key":"715_CR115","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.apjtm.2015.12.013","volume":"9","author":"G Wang","year":"2016","unstructured":"Wang G, Gao M. Influence of Toxoplasma gondii on in-vitro proliferation and apoptosis of hepatoma carcinoma H7402 cell. Asian Pac J Trop Med. 2016;9(1):63\u20136.","journal-title":"Asian Pac J Trop Med"},{"issue":"5","key":"715_CR116","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1111\/jcmm.14207","volume":"23","author":"SG Kim","year":"2019","unstructured":"Kim SG, et al. Increase in the nuclear localization of PTEN by the Toxoplasma GRA16 protein and subsequent induction of p53-dependent apoptosis and anticancer effect. J Cell Mol Med. 2019;23(5):3234\u201345.","journal-title":"J Cell Mol Med"},{"key":"715_CR117","first-page":"137","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, et al. Macrophages polarized by expression of ToxoGRA15II inhibit growth of hepatic carcinoma. Front Immunol. 2017;8:137.","journal-title":"Front Immunol"},{"issue":"1","key":"715_CR118","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0049475518801618","volume":"49","author":"A Abdoli","year":"2019","unstructured":"Abdoli A, et al. Screening of toxoplasmosis in cancer patients: a concern. Trop Doct. 2019;49(1):31\u20134.","journal-title":"Trop Doct"},{"issue":"2","key":"715_CR119","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.canlet.2015.01.036","volume":"359","author":"W Cong","year":"2015","unstructured":"Cong W, et al. Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Lett. 2015;359(2):307\u201313.","journal-title":"Cancer Lett"},{"issue":"11","key":"715_CR120","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/pathogens10111351","volume":"10","author":"D Daher","year":"2021","unstructured":"Daher D, et al. Comprehensive overview of Toxoplasma gondii-induced and associated diseases. Pathogens. 2021;10(11):1351.","journal-title":"Pathogens"},{"key":"715_CR121","first-page":"1","volume":"8","author":"Z-D Wang","year":"2017","unstructured":"Wang Z-D, et al. Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis. Front Microbiol. 2017;8:1\u201312.","journal-title":"Front Microbiol"},{"issue":"4","key":"715_CR122","first-page":"86","volume":"2","author":"DF Ahmed","year":"2017","unstructured":"Ahmed DF, Saheb EJ. The association of Toxoplasma gondii infection in breast and colorectal cancer patients. IJCOCR. 2017;2(4):86\u201392.","journal-title":"IJCOCR"},{"issue":"3","key":"715_CR123","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12639-019-01111-9","volume":"43","author":"MI Ali","year":"2019","unstructured":"Ali MI, et al. Toxoplasma gondii in cancer patients receiving chemotherapy: Seroprevalence and interferon gamma level. J Parasit Dis. 2019;43(3):464\u201371.","journal-title":"J Parasit Dis"},{"issue":"1","key":"715_CR124","doi-asserted-by":"publisher","first-page":"2539482","DOI":"10.1155\/2020\/2539482","volume":"2020","author":"Y Yu","year":"2020","unstructured":"Yu Y, et al. Increased risk of Toxoplasma gondii infection in patients with colorectal cancer in Eastern china: seroprevalence, risk factors, and a case\u2013control study. Biomed Res Int. 2020;2020(1):2539482.","journal-title":"Biomed Res Int"},{"key":"715_CR125","doi-asserted-by":"publisher","first-page":"iv329","DOI":"10.1093\/annonc\/mdh947","volume":"15","author":"J Klastersky","year":"2004","unstructured":"Klastersky J, Aoun M. Opportunistic infections in patients with cancer. Ann Oncol. 2004;15:iv329\u201335.","journal-title":"Ann Oncol"},{"key":"715_CR126","doi-asserted-by":"publisher","first-page":"108544","DOI":"10.1016\/j.exppara.2023.108544","volume":"250","author":"N El Skhawy","year":"2023","unstructured":"El Skhawy N, Eissa MM. Shedding light on a mysterious link between Toxoplasma gondii and cancer: A review. Exp Parasitol. 2023;250:108544.","journal-title":"Exp Parasitol"},{"issue":"2","key":"715_CR127","first-page":"123","volume":"32","author":"Q Luo","year":"2014","unstructured":"Luo Q, et al. Effect of culture supernatant of Toxoplasma gondii on the proliferation and apoptosis of BGC-823 cells. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi \u2018Chinese. J Parasitol Parasitic Diseases\u2019. 2014;32(2):123\u20137.","journal-title":"J Parasitol Parasitic Diseases\u2019"},{"issue":"2","key":"715_CR128","first-page":"17","volume":"30","author":"W Xin","year":"2012","unstructured":"Xin W, et al. Impact of Toxoplasma gondii on the proliferation and apoptosis of tumor cell lines. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. Chin J Parasitol Parasitic Dis. 2012;30(2):17.","journal-title":"Chin J Parasitol Parasitic Dis"},{"issue":"10","key":"715_CR129","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3855\/jidc.12820","volume":"14","author":"EA \u015eahar","year":"2020","unstructured":"\u015eahar EA, et al. Toxoplasma gondii destroys Her2\/Neu-expressing mammary cancer cells in vitro using a continuous feed medium approach. J Infect Dev Ctries. 2020;14(10):1204\u20139.","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"715_CR130","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1292\/jvms.54.7","volume":"54","author":"K Miyahara","year":"1992","unstructured":"Miyahara K, et al. Therapeutic effects of Toxoplasma lysate antigen on 20-methylcholanthrene-induced BALB\/c mouse tumors. J Vet Med Sci. 1992;54(1):7\u201312.","journal-title":"J Vet Med Sci"},{"issue":"2","key":"715_CR131","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4236\/wjv.2012.22014","volume":"2","author":"H Shirzad","year":"2012","unstructured":"Shirzad H, et al. Toxoplasma gondii but not leishmania major or Trichomonas vaginalis decreases cell proliferation and increases cell death on fibrosarcoma cancer cells in culture medium. World J Vaccines. 2012;2(2):105\u20138.","journal-title":"World J Vaccines"},{"issue":"2","key":"715_CR132","first-page":"5","volume":"31","author":"A Elikaei","year":"2018","unstructured":"Elikaei A, Vazini H, Javani F. Anticancer effects of parasite extracts of leishmaniasis and Toxoplasma on resistant cell line (A2780-CP) and sensitive (A2780) to cisplatin. Appl Biol. 2018;31(2):5\u201322.","journal-title":"Appl Biol"},{"key":"715_CR133","doi-asserted-by":"crossref","unstructured":"Payne SN, et al. Novel murine pancreatic tumor model demonstrates immunotherapeutic control of tumor progression by a Toxoplasma gondii protein. Infect Immun. 2021;89(12).","DOI":"10.1128\/IAI.00508-21"},{"issue":"8","key":"715_CR134","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/2326-6066.CIR-14-0235","volume":"3","author":"KL Sanders","year":"2015","unstructured":"Sanders KL, Fox BA, Bzik DJ. Attenuated Toxoplasma gondii stimulates immunity to pancreatic cancer by manipulation of myeloid cell populations. Cancer Immunol Res. 2015;3(8):891\u2013901.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"715_CR135","doi-asserted-by":"publisher","first-page":"e1104447","DOI":"10.1080\/2162402X.2015.1104447","volume":"5","author":"KL Sanders","year":"2016","unstructured":"Sanders KL, Fox BA, Bzik DJ. Attenuated Toxoplasma gondii therapy of disseminated pancreatic cancer generates long-lasting immunity to pancreatic cancer. Oncoimmunology. 2016;5(4):e1104447.","journal-title":"Oncoimmunology"},{"issue":"6","key":"715_CR136","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/infdis\/124.6.587","volume":"124","author":"JB Hibbs Jr","year":"1971","unstructured":"Hibbs JB Jr, Lambert LH Jr, Remington JS. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and besnoitia Jellisoni. J Infect Dis. 1971;124(6):587\u201392.","journal-title":"J Infect Dis"},{"issue":"1","key":"715_CR137","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s13071-021-05032-6","volume":"14","author":"L-Q Xu","year":"2021","unstructured":"Xu L-Q, et al. A uracil auxotroph Toxoplasma gondii exerting Immunomodulation to inhibit breast cancer growth and metastasis. Parasit Vectors. 2021;14(1):601.","journal-title":"Parasit Vectors"},{"issue":"1","key":"715_CR138","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3347\/PHD.24082","volume":"63","author":"BK Kim","year":"2025","unstructured":"Kim BK, et al. Anti-tumor effects of Toxoplasma gondii and antigen-pulsed dendritic cells in mice bearing breast cancer. Parasites Hosts Dis. 2025;63(1):37.","journal-title":"Parasites Hosts Dis"},{"issue":"Suppl","key":"715_CR139","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.3346\/jkms.2007.22.S.S38","volume":"22","author":"J-O Kim","year":"2007","unstructured":"Kim J-O, et al. Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and Inhibition of angiogenesis. J Korean Med Sci. 2007;22(Suppl):S38.","journal-title":"J Korean Med Sci"},{"issue":"4","key":"715_CR140","first-page":"400","volume":"31","author":"J Yu-Meng","year":"2019","unstructured":"Yu-Meng J, et al. Inhibition of Toxoplasma gondii excretory-secretory antigens on growth of murine Lewis lung carcinoma. Chin J Schistosomiasis Control. 2019;31(4):400.","journal-title":"Chin J Schistosomiasis Control"},{"issue":"2","key":"715_CR141","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3347\/kjp.2009.47.2.175","volume":"47","author":"HY Darani","year":"2009","unstructured":"Darani HY, et al. Effects of Toxoplasma gondii and Toxocara canis antigens on WEHI-164 fibrosarcoma growth in a mouse model. Korean J Parasitol. 2009;47(2):175.","journal-title":"Korean J Parasitol"},{"key":"715_CR142","unstructured":"Amari A et al. Effects of dendritic cell vaccine activated with protein components of Toxoplasma gondii on tumor specific CD8\u2009+\u2009T-cells. Tehran Univ Med J. 2009;67(9)."},{"issue":"10","key":"715_CR143","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1128\/CVI.00199-09","volume":"16","author":"M Motamedi","year":"2009","unstructured":"Motamedi M, et al. Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii. Clin Vaccine Immunol. 2009;16(10):1393\u20138.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"715_CR144","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3347\/kjp.2010.48.2.171","volume":"48","author":"K-H Pyo","year":"2010","unstructured":"Pyo K-H, et al. Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB\/c mice. Korean J Parasitol. 2010;48(2):171.","journal-title":"Korean J Parasitol"},{"issue":"9","key":"715_CR145","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/apm.12420","volume":"123","author":"R Boghozian","year":"2015","unstructured":"Boghozian R, et al. Identification of Toxoplasma gondii protein fractions induce immune response against melanoma in mice. Apmis. 2015;123(9):800\u20139.","journal-title":"Apmis"},{"issue":"10","key":"715_CR146","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.4049\/jimmunol.166.10.5878","volume":"166","author":"CA Hunter","year":"2001","unstructured":"Hunter CA, et al. Cutting edge: systemic Inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis. J Immunol. 2001;166(10):5878\u201381.","journal-title":"J Immunol"},{"issue":"3","key":"715_CR147","first-page":"301","volume":"23","author":"JY Jiao YuMeng","year":"2011","unstructured":"Jiao YuMeng JY, et al. Effects of excreted\/secreted antigens of Toxoplasma gondii on CD4\u2009+\u2009CD25\u2009+\u2009Foxp3\u2009+\u2009T cells and NK cells of melanoma-bearing mice. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011;23(3):301\u20136.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"7","key":"715_CR148","doi-asserted-by":"publisher","first-page":"e1006189","DOI":"10.1371\/journal.pgen.1006189","volume":"12","author":"BA Fox","year":"2016","unstructured":"Fox BA, et al. Secretion of Rhoptry and dense granule effector proteins by nonreplicating Toxoplasma gondii uracil auxotrophs controls the development of antitumor immunity. PLoS Genet. 2016;12(7):e1006189.","journal-title":"PLoS Genet"},{"issue":"3","key":"715_CR149","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/jnci\/59.3.963","volume":"59","author":"FK Conley","year":"1977","unstructured":"Conley FK, Remington JS. Nonspecific Inhibition of tumor growth in the central nervous system: observations of intracerebral Ependymoblastoma in mice with chronic Toxoplasma infection. J Natl Cancer Inst. 1977;59(3):963\u201373.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"715_CR150","doi-asserted-by":"publisher","first-page":"e001242","DOI":"10.1136\/jitc-2020-001242","volume":"8","author":"L Lantier","year":"2020","unstructured":"Lantier L, et al. Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer. J Immunother Cancer. 2020;8(2):e001242.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"715_CR151","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/ijehe.ijehe_13_21","volume":"11","author":"HY Darani","year":"2022","unstructured":"Darani HY, Sharafi SM. Effect of hydatid cyst antigens polyspecific antisera on breast cancer cells (4T1) growth in cell culture medium. Int J Env Health Eng. 2022;11(1):15.","journal-title":"Int J Env Health Eng"},{"issue":"11","key":"715_CR152","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/ph15111421","volume":"15","author":"L Eligio Garc\u00eda","year":"2022","unstructured":"Eligio Garc\u00eda L, et al. Trypanosoma Cruzi antigenic proteins shared with acute lymphoblastic leukemia and neuroblastoma. Pharmaceuticals. 2022;15(11):1421.","journal-title":"Pharmaceuticals"},{"issue":"24","key":"715_CR153","doi-asserted-by":"publisher","first-page":"13577","DOI":"10.3390\/ijms252413577","volume":"25","author":"VA Maravelez Acosta","year":"2024","unstructured":"Maravelez Acosta VA, et al. Association of neuroblastoma (nb) SH-SY5Y cells with antibodies of parasitic origin (anti-Acanthamoeba and anti-Toxocara canis). Int J Mol Sci. 2024;25(24):13577.","journal-title":"Int J Mol Sci"},{"issue":"23","key":"715_CR154","doi-asserted-by":"publisher","first-page":"15032","DOI":"10.3390\/ijms232315032","volume":"23","author":"T Freire","year":"2022","unstructured":"Freire T, et al. Trypanosoma cruzi-derived molecules induce anti-tumour protection by favouring both innate and adaptive immune responses. Int J Mol Sci. 2022;23(23):15032.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"715_CR155","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1007\/s00262-021-02948-x","volume":"70","author":"E Berriel","year":"2021","unstructured":"Berriel E, et al. Human hydatid cyst fluid-induced therapeutic anti-cancer immune responses via NK1. 1\u2009+\u2009cell activation in mice. Cancer Immunol Immunother. 2021;70(12):3617\u201327.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"715_CR156","first-page":"183","volume":"10","author":"F Mohamadi","year":"2019","unstructured":"Mohamadi F, et al. Anti-Toxoplasma gondii antibodies attach to mouse cancer cell lines but not normal mouse lymphocytes. Biomed Rep. 2019;10(3):183\u20138.","journal-title":"Biomed Rep"},{"issue":"1","key":"715_CR157","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ijc.2910410114","volume":"41","author":"S Angsubhakorn","year":"1988","unstructured":"Angsubhakorn S, et al. Reducing effects of rodent malaria on hepatic carcinogenesis induced by dietary aflatoxin B1. Int J Cancer. 1988;41(1):69\u201373.","journal-title":"Int J Cancer"},{"key":"715_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-020-00570-5","volume":"18","author":"B Wang","year":"2020","unstructured":"Wang B, et al. Plasmodium infection inhibits tumor angiogenesis through effects on tumor-associated macrophages in a murine implanted hepatoma model. Cell Commun Signal. 2020;18:1\u201317.","journal-title":"Cell Commun Signal"},{"key":"715_CR159","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1007\/s00436-020-06872-4","volume":"119","author":"Y Lu","year":"2020","unstructured":"Lu Y, et al. Immunomodulatory action of excretory-secretory products of Angiostrongylus cantonensis in a mouse tumour model. Parasitol Res. 2020;119:3705\u201318.","journal-title":"Parasitol Res"},{"key":"715_CR160","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00005-014-0292-z","volume":"62","author":"M Abdel-Latif","year":"2014","unstructured":"Abdel-Latif M, et al. Effect of diethylcarbamazine citrate and setaria equina excretory\u2013secretory material on rat hepatocellular carcinoma. Arch Immunol Ther Exp. 2014;62:511\u201320.","journal-title":"Arch Immunol Ther Exp"},{"key":"715_CR161","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.envpol.2013.07.046","volume":"182","author":"EJ Calabrese","year":"2013","unstructured":"Calabrese EJ. Biphasic dose responses in biology, toxicology and medicine: accounting for their generalizability and quantitative features. Environ Pollut. 2013;182:452\u201360.","journal-title":"Environ Pollut"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00715-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:24:40Z","timestamp":1768472680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-025-00715-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":161,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["715"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00715-6","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Faculty of Medicine, Alexandria University (Permit Number: 0306454).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The participants\/ their legal guardians gave informed consent for participation in the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agreed to the publication of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}